Valhi (VHI) Competitors $15.50 +0.22 (+1.41%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$15.50 +0.01 (+0.03%) As of 08/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VHI vs. CC, UAN, NGVT, BAK, ECVT, WLKP, ASPI, TROX, OEC, and ASIXShould you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), CVR Partners (UAN), Ingevity (NGVT), Braskem (BAK), Ecovyst (ECVT), Westlake Chemical Partners (WLKP), ASP Isotopes (ASPI), Tronox (TROX), Orion (OEC), and AdvanSix (ASIX). These companies are all part of the "chemicals" industry. Valhi vs. Its Competitors Chemours CVR Partners Ingevity Braskem Ecovyst Westlake Chemical Partners ASP Isotopes Tronox Orion AdvanSix Chemours (NYSE:CC) and Valhi (NYSE:VHI) are both small-cap basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings. Does the media prefer CC or VHI? In the previous week, Chemours had 18 more articles in the media than Valhi. MarketBeat recorded 24 mentions for Chemours and 6 mentions for Valhi. Chemours' average media sentiment score of 0.53 beat Valhi's score of -0.23 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 5 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Valhi 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CC or VHI a better dividend stock? Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 2.9%. Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 2.1%. Chemours pays out -12.5% of its earnings in the form of a dividend. Valhi pays out 7.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemours is clearly the better dividend stock, given its higher yield and lower payout ratio. Do analysts rate CC or VHI? Chemours presently has a consensus target price of $17.38, indicating a potential upside of 42.53%. Valhi has a consensus target price of $12.00, indicating a potential downside of 22.56%. Given Chemours' stronger consensus rating and higher possible upside, equities research analysts clearly believe Chemours is more favorable than Valhi.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemours 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63Valhi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Which has more volatility & risk, CC or VHI? Chemours has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Valhi has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CC or VHI? 76.3% of Chemours shares are held by institutional investors. Comparatively, 3.8% of Valhi shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 0.2% of Valhi shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is CC or VHI more profitable? Valhi has a net margin of 4.69% compared to Chemours' net margin of -7.19%. Chemours' return on equity of 35.14% beat Valhi's return on equity.Company Net Margins Return on Equity Return on Assets Chemours-7.19% 35.14% 2.45% Valhi 4.69%7.08%3.53% Which has stronger valuation & earnings, CC or VHI? Valhi has lower revenue, but higher earnings than Chemours. Chemours is trading at a lower price-to-earnings ratio than Valhi, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemours$5.78B0.32$86M-$2.80-4.35Valhi$2.10B0.21$108M$4.103.78 SummaryChemours beats Valhi on 13 of the 18 factors compared between the two stocks. Get Valhi News Delivered to You Automatically Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHI vs. The Competition Export to ExcelMetricValhiCHEM IndustryMaterials SectorNYSE ExchangeMarket Cap$432.34M$11.25B$3.30B$20.70BDividend Yield2.09%3.96%5.18%3.67%P/E Ratio4.5225.05109.8328.45Price / Sales0.215.6331,322,622,491,743,400.0056.04Price / Cash2.477.0923.9623.21Price / Book0.321.706.014.33Net Income$108M$507.50M$148.72M$996.14M7 Day Performance0.68%1.69%3.80%1.98%1 Month Performance-18.79%-7.28%4.05%-0.84%1 Year Performance-19.17%-0.20%37.16%14.36% Valhi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHIValhi1.2535 of 5 stars$15.50+1.4%$12.00-22.6%-8.4%$432.34M$2.10B4.522,524News CoverageEarnings ReportDividend AnnouncementGap UpCCChemours4.5928 of 5 stars$12.17+5.8%$17.44+43.3%-33.2%$1.72B$5.78B60.856,000Earnings ReportDividend CutUANCVR Partners2.2811 of 5 stars$97.30+1.7%N/A+31.5%$1.64B$525.32M11.69300Dividend IncreaseNGVTIngevity1.5743 of 5 stars$40.84+1.1%$57.00+39.6%+42.1%$1.47B$1.41B-4.191,600News CoverageEarnings ReportAnalyst ForecastBAKBraskem2.3819 of 5 stars$3.07+0.8%$9.75+218.1%-48.1%$1.21B$14.36B-0.738,382News CoverageEarnings ReportGap UpECVTEcovyst3.5263 of 5 stars$8.29-1.8%$10.00+20.7%+26.7%$990.86M$704.50M-82.86880News CoverageEarnings ReportWLKPWestlake Chemical Partners4.0734 of 5 stars$21.83+0.1%N/A-3.5%$768.91M$1.14B14.65150News CoverageEarnings ReportAnalyst UpgradeASPIASP Isotopes0.6938 of 5 stars$9.40+5.3%$6.67-29.1%+331.5%$749.28M$4.14M-15.4176News CoverageTROXTronox4.7935 of 5 stars$3.19-6.3%$6.51+104.3%-75.7%$538.77M$3.07B-2.026,500Trending NewsDividend CutAnalyst ForecastHigh Trading VolumeOECOrion2.6678 of 5 stars$9.38+1.4%$13.00+38.7%-42.0%$520.49M$1.88B20.381,658News CoverageEarnings ReportASIXAdvanSix4.1961 of 5 stars$18.94-1.3%$33.50+76.9%-35.6%$514.54M$1.52B6.671,450Dividend Announcement Related Companies and Tools Related Companies Chemours Alternatives CVR Partners Alternatives Ingevity Alternatives Braskem Alternatives Ecovyst Alternatives Westlake Chemical Partners Alternatives ASP Isotopes Alternatives Tronox Alternatives Orion Alternatives AdvanSix Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VHI) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valhi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Valhi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.